IMNM
Price
$8.08
Change
+$0.08 (+1.00%)
Updated
Apr 22, 02:31 PM (EDT)
Capitalization
695.61M
16 days until earnings call
SYRE
Price
$13.57
Change
-$0.00 (-0.00%)
Updated
Apr 22, 02:48 PM (EDT)
Capitalization
817.94M
16 days until earnings call
Ad is loading...

IMNM vs SYRE

Header iconIMNM vs SYRE Comparison
Open Charts IMNM vs SYREBanner chart's image
Immunome
Price$8.08
Change+$0.08 (+1.00%)
Volume$100
Capitalization695.61M
Spyre Therapeutics
Price$13.57
Change-$0.00 (-0.00%)
Volume$441
Capitalization817.94M
IMNM vs SYRE Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. SYRE commentary
Apr 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and SYRE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 22, 2025
Stock price -- (IMNM: $8.00 vs. SYRE: $13.57)
Brand notoriety: IMNM and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 76% vs. SYRE: 98%
Market capitalization -- IMNM: $695.61M vs. SYRE: $817.94M
IMNM [@Biotechnology] is valued at $695.61M. SYRE’s [@Biotechnology] market capitalization is $817.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $285.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 5 TA indicator(s) are bullish while SYRE’s TA Score has 6 bullish TA indicator(s).

  • IMNM’s TA Score: 5 bullish, 3 bearish.
  • SYRE’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а +8.84% price change this week, while SYRE (@Biotechnology) price change was +4.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.58%. For the same industry, the average monthly price growth was -9.22%, and the average quarterly price growth was -11.85%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($818M) has a higher market cap than IMNM($696M). IMNM YTD gains are higher at: -24.670 vs. SYRE (-41.710). IMNM has higher annual earnings (EBITDA): -109.95M vs. SYRE (-208.57M). SYRE has more cash in the bank: 603M vs. IMNM (240M). SYRE has less debt than IMNM: SYRE (0) vs IMNM (2.72M). IMNM has higher revenues than SYRE: IMNM (10.1M) vs SYRE (0).
IMNMSYREIMNM / SYRE
Capitalization696M818M85%
EBITDA-109.95M-208.57M53%
Gain YTD-24.670-41.71059%
P/E RatioN/A1.72-
Revenue10.1M0-
Total Cash240M603M40%
Total Debt2.72M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMSYRE
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PKSCX33.93N/A
N/A
Virtus KAR Small-Cap Core C
SSDAX27.78N/A
N/A
DWS Small Cap Growth A
SCIRX88.54N/A
N/A
Columbia Seligman Tech & Info R
STVYX17.13N/A
N/A
SEI Tax-Managed Mgd Volatility Y (SIMT)
JGRRX18.60N/A
N/A
JAG Large Cap Growth R

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+1.14%
KYMR - IMNM
55%
Loosely correlated
+4.58%
IDYA - IMNM
54%
Loosely correlated
+6.44%
RXRX - IMNM
53%
Loosely correlated
-1.64%
BEAM - IMNM
53%
Loosely correlated
+7.29%
SYRE - IMNM
50%
Loosely correlated
+7.10%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with CGON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+7.10%
CGON - SYRE
53%
Loosely correlated
-1.11%
APGE - SYRE
52%
Loosely correlated
-0.79%
ACLX - SYRE
51%
Loosely correlated
-1.76%
IMNM - SYRE
50%
Loosely correlated
+1.14%
PRME - SYRE
48%
Loosely correlated
+12.10%
More